Continuous Warfarin (Antithrombin therapy) administration versus Heparin bridge therapy in post colon polypectomy hemorrhage
Not Applicable
- Conditions
- colon polyp
- Registration Number
- JPRN-UMIN000023720
- Lead Sponsor
- Osaka City University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 316
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients have already registered 2)Patients with inflammatory bowel disease, familial adenomatous polyposis, or Peutz-Jeghers syndrome 3)We cannot observe the progress of the patients 4)patients with bleeding within 6 weeks before the procedure 5)Patients who undergo hemodialys 6)Plt is less than 50000/mm3 7)Patients with the abnormality in blood coagulation ability 8)Woman who is during pregnancy 9)Patients are nursing mothers 10)Patients have an allergy to warfarin or heparin. 11)The attending physician has determined that it is difficult to entry
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the incidence of post polypectomy and EMR bleeding
- Secondary Outcome Measures
Name Time Method 1 cumulative post polypectomy and EMR bleeding rate 2 the rate of overt bleeding which dose not satisfy the definiton of post polypectomy and EMR bleeding 3 the rate of immediate bleeding requiring endoscopic intervention 4 immediate bleeding requiring angiography or surgery or blood transfusion 5 general incidence of bleeding 6 risk factors for post polypectomy and EMR bleeding 7 days of hospital stay 8 the incidence of thromboembolism 9 PT-INR at 28 days after polypectomy and EMR 10 the incidence of serious adverse event